Pharmaceutical Society of Great

Handbook of Pharmaceutical Excipients American Pharmaceutical Association/The Pharmaceutical Society of Great Britain, Washington, D.C. and London, 1986, pp. 19, 99, 101, 145, 240, 333. 

The US. Pharmacopeia (USP XXII) or National Formula (NFXVII) (20) also provide a similar description however, the peroxide value is not defined (Table 9). These specifications are also given in the Handbook of Pharmaceutical Excipients (HPE), pubhshed jointiy by the American Pharmaceutical Association and The Pharmaceutical Society of Great Britain (21), which defines lecithins both from plants and eggs. The Merck Index (22) specifies a slightiy lower acid value. The Japanese Monograph (ISCI-II) (23) specifies a slightiy lower acetone-insoluble matter and a lower heavy-metal content. 

Perhaps the first international attempt at harmonization involved excipients and a collaborative effort between scientists in the United States and the United Kingdom. The goal was to develop common descriptions and physical standards for the most commonly used excipients. The project was supported by the American Pharmaceutical Association and the Pharmaceutical Society of Great Britain, who together... 

Aikens JE, Nease Jr DE et aL (2005) Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 3 23-30 Blenkinsopp A, Bond C, Britten N (1997) From compliance to concordance. Achieving shared goals in medicine taking. Royal Pharmaceutical Society of Great Britain and Merck Sharpe Dome, London UK... 

Royal Pharmaceutical Society (1997) From compliance to concordance towards shared goals in medicine taking. Royal Pharmaceutical Society of Great Britain, London... 

Snell M, ed (2008). Medicines, Ethics and Practice a guide for pharmacists and pharmacy technicians, 32nd rev edn. London Royal Pharmaceutical Society of Great Britain. Sweetman SC, ed (2006). Martindale the Complete Drug Reference, 35th edn. London Pharmaceutical Press. 

Medicines, Ethics and Practice a Guide for Pharmacists and Pharmacy Technicians, 32, July 2008. London Royal Pharmaceutical Society of Great Britain, 2008. 

From Casy and Hassan, by courtesy of The Pharmaceutical Society of Great Britain.)... 

In the period intervening between its interim advice and its final report, the Joint Subcommittee received memoranda from, and met representatives of, the Association of the British Pharmaceutical Industry (ABPl), the BMA, the Pharmaceutical Society of Great Britain and the College of General Practitioners. 

British Medical Association and the Pharmaceutical society of Great Britain, appearing first in 1949 and then every 3 years until 1979. 

The Royal Pharmaceutical Society of Great Britain has issued guidance in relation to the acceptance of gifts and inducements to prescribe or supply. The Society states that pharmacists accepting items such as gift vouchers, bonus points, discount holidays, sports equipment etc would be in breach of the Society s Code of Ethics and advises pharmacists not to participate in such offers. 

Methods of sale of medicines through pharmacies are also covered by the Code of Ethics of the Royal Pharmaceutical Society of Great Britain. 

Copies of the published reports are sent to the Medicines and Healthcare products Regulatory Agency, the Office of Fair Trading, the British Medical Association, the Royal Pharmaceutical Society of Great Britain and the Editors of the BMJ and The Pharmaceutical Journal. Copies of the published reports are also available to anyone on request. 

Michael J. Groves, a pharmacist with a doctorate in chemical engineering, has spent much of his career working in industry and academe. Now retired, his scientific interests include dispersed drug delivery systems and quality control issues for parenteral drug products. Editor or joint editor of a number of books, he has published 400 research papers, patents, reviews, and book reviews. He is a Fellow of the Royal Pharmaceutical Society of Great Britain, the Institute of Biology, and the American Association of Pharmaceutical Scientists. 

British Medical Association and Pharmaceutical Society of Great Britain 1963, British National Formulary, Alternative Edition, based on a pharmacological classification edn, British Medical Association and Pharmaceutical Society of Great Britain, London. 

The following year, the British National Formulary, a joint publication of the British Medical Association and Royal Pharmaceutical Society of Great Britain (1991), listed suicidal ideation and violent behavior as fluoxetine side effects. Also in 1991,1 published Toxic Psychiatry, in which I observed for the first time that Prozac was producing a continuum of overstimulation that included akathisia, agitation, anxiety, insomnia, depression and mania, and, in the extreme, suicide and violence. I drew on previously sequestered FDA premarketing data on Prozac, the scientific literature, and my own clinical and forensic cases. 

British Medical Association and Royal Pharmaceutical Society of Great Britain. (1991, September). British national formulary (BNF). London Pharmaceutical Press. Brodal, A. (1969). Neurological anatomy. New York Oxford University Press. 

---